SEC Filing Summary
Filing: Form 8-K, Item 8.01 (Other Events), dated February 4, 2021. The provided filing identifies the registrant as Agrify Corporation, not RYTHM, Inc.; investors should verify the company identity and ticker. Agrify’s common stock traded under ticker AGFY on Nasdaq.
Business Context and Reporting Period
The filing reports the closing of the underwriters’ over-allotment option in connection with Agrify’s initial public offering. It does not present quarterly or annual operating results. The relevant event occurred on February 4, 2021, following the IPO closing on February 1, 2021.
Key Financial Metrics and Capitalization
| Metric | Reported amount |
|---|---|
| Additional shares sold under over-allotment | 810,000 shares |
| Offering price | $10.00 per share |
| Total IPO shares sold | 6,210,000 shares |
| Total net IPO proceeds | Approximately $57 million, after underwriting discounts and estimated offering expenses |
| Underwriting commission on over-allotment shares | 7% |
The filing does not provide revenue, profit, cash flow, operating margins, debt, liquidity balances, or other operating performance metrics.
Material Changes Versus the Prior Comparable Period
No comparable-period financial information is included. The material change described is the increase in total IPO proceeds and shares sold resulting from the exercise of the full 810,000-share over-allotment option.
Guidance, Outlook, Risks, and Unusual Items
No management guidance, outlook, risk update, contingencies, or unusual operating items are disclosed in this filing. The principal financing event was the completion of the IPO over-allotment sale, which increased the company’s equity capital by approximately $57 million net in total.
Important Facts to Verify
- Confirm that the filing belongs to Agrify Corporation rather than RYTHM, Inc.
- Verify the final net proceeds after all underwriting discounts, commissions, and offering expenses.
- Review the IPO prospectus for the intended use of proceeds, dilution, pre-IPO capitalization, and related risk factors.
- Confirm the total post-offering shares outstanding, including shares issued before the IPO and any securities convertible into common stock.
- Assess subsequent filings for the company’s actual liquidity, operating results, and use of the IPO proceeds.